Norcliffe Capital is a venture fund focused on seed-stage investments in health tech and biotech sectors. They invest in companies with proven intellectual property that aim for significant impact. With decades of experience, they provide not only funding but also expertise and guidance. Operating in the UK and EEA, they aim to generate positive returns through various exit routes. Norcliffe Capital collaborates with financial advisers, wealth managers, and individual investors, offering tax-efficient investment methods like the Enterprise Investment Scheme (EIS), SIPP, SSAS, and direct equity. Notable investments include Glen Clova Scientific.
